• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/088 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Patent holdings for IPC class C07D 295/088

Total number of patents in this class: 446

10-year publication summary

32
31
24
30
35
29
22
29
30
6
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Alkermes Pharma Ireland Limited
256
14
Corsair Pharma, Inc.
37
14
FUJIFILM Corporation
30106
11
The University of British Columbia
1538
10
Dow Global Technologies LLC
10720
9
Novartis AG
10462
8
British Columbia Cancer Agency Branch
186
8
The United States of America, as represented by the Secretary, Department of Health and Human Services
2952
7
BASF SE
21151
6
The Scripps Research Institute
1341
6
Gotion Inc.
39
6
Translate bio, Inc.
415
6
Sumitomo Chemical Company, Limited
9058
5
Board of Regents, The University of Texas System
6020
5
The Trustees of Columbia University in the City of New York
3611
5
Emory University
1688
5
Wave Life Sciences Ltd.
193
5
Sanofi
4157
5
Cassava Science, Inc.
13
5
Merck Patent GmbH
5732
4
Other owners 302